Pfizer Outlines Common Pitfalls Leading to Prosecution in the Pharma Industry

LONDON, April 25, 2012 /PRNewswire/ --

Joshua Holzer, Chief Compliance Counsel for Global Trade, Pfizer Inc, recently joined Pharma IQ to discuss the common pitfalls experienced by pharma companies when it comes to compliance with regulatory investigations and he also shared strategies that in house counsels can use to help their company protect themselves and better manage their compliance.

When speaking with Pharma IQ, Mr Holzer discussed how the global nature of commerce increasingly forces companies to look at their level of compliance with global trade laws: import laws, export laws as well as the sanctions and embargoes areas.

"They're putting resources towards dealing with those areas and they're particularly important because they're really complex and in-depth and the laws do change from country to country and they should be harmonised but they're not necessarily that way," says Mr Holzer.

During the interview, he also discussed actions the pharma companies should take immediately upon discovering wrongdoing and key steps Pfizer takes when developing a regulatory investigation plan, particularly in a multijurisdictional situation.

You can listen to the full interview on Pharma IQ web: http://bit.ly/HPWHA9

This interview was conducted in relation to Pharma IQ's Information Governance & eDiscovery for Pharma, Biotech and Medical Devices, taking place 26 - 28 June, 2012, London, UK

The feedback from Mr Holzer helped to shape the agenda that features The Honorable Andrew J Peck, Director, US Magistrate Judge District of New York, Master Steven Whitaker, Senior Master of the Senior Courts in the Queen's Bench Division from The Royal Courts of Justice and  Judge Abeline Dorethea Reiling, Vice-President from Amsterdam District Court who will be leading a judge panel Discovery in the Courtroom: Understanding emerging judicial expectations for eDiscovery in European and American courts.

Other important topics expressed by survey respondents and will be discussed at the event include:

• Outsourcing Sandwich Records Management: Redesigning the records management support model at Pfizer (Frank AF Hultschig
  Director, Enterprise Records and Information Management, Corporate Legal
  Pfizer)
• Regulatory expectations: Update on US and European regulatory investigations and prosecutions (Jean-Bernard Schmid
  Deputy Prosecutor General, Investigating Magistrate
  Geneva
• Privacy vs Litigation: Practical Considerations for the Life Sciences Industry (Peter B. Miller, Acting Chief Privacy Officer, US Federal Trade Commission)

To download the podcast or to find out more about Information Governance & eDiscovery for Pharma, Biotech and Medical Devices,please visit http://www.pharmaediscovery.com/NEWS, email [email protected] or call +44(0)20-7036-1300.

Media contact: Joanna, +44(0)20-7368-9807, [email protected] - Please contact for more information or images.

Press are invited to attend this important industry forum, if you would like to a complimentary press pass please email Joanna Checinska (

[email protected])

SOURCE Pharma IQ